Texas Childrens Hospital/Baylor College of Medicine
Houston, Texas 77094
14 studies enrolling now · 68 studies all time
What they study most
ALL, AML, AML, Childhood, Achondroplasia, Acute Graft vs Host Disease, Acute Liver Failure, Acute Lymphoblastic Leukemia, Acute Migraine, Acute Respiratory Distress Syndrome, Acute Undifferentiated Leukemia, Advanced Unresectable Solid Tumors, Adverse Effects
Studies at this site
- A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections — Recruiting now
- Streamlined Treatment of Pulmonary Exacerbations in Pediatrics — Recruiting now
- Optimizing Pain Treatment in Children On Mechanical Ventilation — Recruiting now
- Primary Sclerosing Cholangitis in Children — Recruiting now
- TSC Biosample Repository and Natural History Database — Recruiting now
- Nephrotic Syndrome Study Network — Recruiting now
- Biliary Atresia Study in Infants and Children — Recruiting now
- Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma — Recruiting now
- Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study — Recruiting now
- Clinical Effectiveness of the "PICU Up!" Multifaceted Early Mobility Intervention for Critically Ill Children — Recruiting now
- Arginine Metabolism in Youth With Type 2 Diabetes — Recruiting now
- Fecal Microbiota Transplant National Registry — Recruiting now
- Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies — Recruiting now
- Dead Space and Inhaled Nitric Oxide in Pediatric Acute Respiratory Distress Syndrome — Recruiting now
- Child and Adolescent Registry for Participants With Narcolepsy — Recruiting now
- Biologic Abatement and Capturing Kids' Outcomes and Flare Frequency in Juvenile Spondyloarthritis — Completed
- Phase 1/2 Study of FRF-001, an AAV-9 Gene Therapy, in Patients With FOXG1 Syndrome (FS) — Enrolling by invitation
- A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy — Running, not enrolling
- Genetic Collection Protocol — Completed
- Trial of Indication-Based Transfusion of Red Blood Cells in ECMO — Running, not enrolling
- Sickle Cell Disease Treatment With Arginine Therapy (STArT) Trial — Completed
- Longitudinal Study of Mitochondrial Hepatopathies — Paused
- Pediatric GVHD Low Risk Steroid Taper Trial — Completed
- Study of the Efficacy and Safety of AMAG-423 (Digoxin Immune Fab) in Antepartum Subjects With Severe Preeclampsia — Stopped early
- A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension — Completed
- Safety and Efficacy of GS-100 Gene Therapy in Patients With NGLY1 Deficiency — Running, not enrolling
- Linking Endotypes and Outcomes in Pediatric Acute Respiratory Distress Syndrome — Completed
- STaph Aureus Resistance-Treat Early and Repeat (STAR-TER) — Completed
- Preventing Asthma in High Risk Kids — Running, not enrolling
- A Study of FORE8394 as a Single Agent in Patients With Advanced Unresectable Solid Tumors — Completed
- Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency — Completed
- Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency As Open Label Extension — Completed
- International Fetal Anesthesia Database — Running, not enrolling
- Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer — Completed
- A Study of ALS-008176 in Infants Hospitalized With RSV — Completed
- Longer-term Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008) — Completed
- A Phase 3 Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Heterozygous for F508del and a Minimal Function Mutation (F/MF) — Completed
- Establishing a Pediatric Reference Range for the 13C-Spirulina Gastric Emptying Breath Test (GEBT) — Completed
- FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE) — Completed
- Continuation Study of Long-term Safety, Tolerability, Pharmacokinetics and Efficacy of Recifercept in Achondroplasia — Stopped early
- Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors — Completed
- Approaches and Decisions for Acute Pediatric TBI Trial — Completed
- Validation of a Salivary miRNA Diagnostic Test for ASD — Status unconfirmed
- Nivolumab in Combination With 5-azacytidine in Childhood Relapsed/Refractory AML — Status unconfirmed
- PALISADE Follow-on Study (ARC004) — Completed
- AR101 Real-World Open-Label Extension Study — Completed
- Real-World AR101 Market-Supporting Experience Study in Peanut-Allergic Children (RAMSES) — Completed
- Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995 — Status unconfirmed
- Optimizing Self-Management Adherence and Glycemic Control in Older Teens With Type 1 Diabetes: The Teenwork Study — Completed
- Dexmedetomidine in Pediatric Tonsillectomy — Completed